Showing results (501-510 of 4,041) with videos related to
Sort By:
Pageof 405
Pharmacoepidemiology and Drug Safety|November 27, 2013
Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockersDavid J Graham, Esther H Zhou, Stephen McKean, et al.Pharmacoepidemiology and Drug Safety|October 16, 2013
Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based studyKhedidja Hedna, Staffan Hägg, Karolina Andersson Sundell, et al.Pharmacoepidemiology and Drug Safety|October 17, 2013
Risk factors for venous thromboembolism during pregnancyThomas Bo Jensen, Thomas Alexander Gerds, Randi Grøn, et al.Pharmacoepidemiology and Drug Safety|October 19, 2013
Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashesMarta Avalos, Ludivine Orriols, Hélène Pouyes, et al.Pharmacoepidemiology and Drug Safety|June 8, 2012
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug usersHilda J I de Jong, Rob J Vandebriel, Siti R F Saldi, et al.Pharmacoepidemiology and Drug Safety|June 8, 2012
A retrospective study on the usage of antiepileptic drugs in Asian children from 2000 to 2009 in the largest pediatric hospital in SingaporeWei Wei Tan, Sing Teang Kong, Derrick W S Chan, et al.Pharmacoepidemiology and Drug Safety|June 8, 2012
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisionsRyan D Kilpatrick, Dave Gilbertson, M Alan Brookhart, et al.Pharmacoepidemiology and Drug Safety|January 16, 2010
Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disordersLianna Ishihara, David J Webb, Michael Irizarry, et al.Pharmacoepidemiology and Drug Safety|May 1, 2002
Ethical issues arising in pharmacoepidemiologic research in a community hospital in Crete, GreeceL TzimisPharmacoepidemiology and Drug Safety|May 1, 2002
The ethical issues of the postmarketing surveillance of drug teratogenicity in HungaryA E CzeizelPageof 405